Navigation Links
Defined Health Announces Final Speaker Roster and Agenda for Therapeutic Insight 2008

FLORHAM PARK, N.J., April 9 /PRNewswire/ -- Defined Health has announced the final agenda and speaker list for its 8th annual Therapeutic Insight conference. Therapeutic Insight 2008 ("TI2008") will take place on April 28 - 30, 2008, at The Westin New York at Times Square. The following industry decision-makers and key opinion leaders will discuss relevant pharma/biotech issues and current trends in oncology, cardiovascular disease, neuropsychiatric disorders, antimicrobials, therapeutic vaccines and orphan diseases:

* Professor Ruth Arnon, The Paul Ehrlich Professor of Immunology,

Weizmann Institute of Science

* Charles Baum, MD, PhD, Vice President, Global R&D, Oncology, Pfizer

* Karen Bernstein, PhD, Chairman and Editor-in-Chief, BioCentury

* Thomas P. Blackburn, PhD, DSc, TPBioVentures LLC

* Jeffrey M. Bockman, PhD, Vice President, Defined Health

* Michael R. Bristow, MD, PhD, Founder, Chairman and Chief Science and

Medical Officer, ARCA Discovery

* Leslie J. Browne, PhD, President & CEO, Pharmacopeia Inc.

* Shannon Brownlee, Schwartz Senior Fellow, New American Foundation

* Michael D. Clayman, MD, CEO, Flexion Therapeutics

* Earl M. (Duke) Collier, Jr., JD, Executive Vice President, Genzyme


* Albert R. Collinson, PhD, Chief Business Officer, Rib-X Pharmaceuticals

* Lode Debrabandere, PhD, Vice President & General Manager Inflammatory

Diseases, Osiris

* Mark W. Frohlich, MD, Senior VP & Chief Medical Officer, Dendreon


* Matthew Gantz, Chief Executive Officer & Founder, Acureon Pharma

* Milton H. Grannatt, PhD, Vice President and Head, Negotiations, New

Growth Opportunities, Global Business Development & Licensing, Novartis

Pharmaceuticals Corporation

* Russell Hagan, PhD, Senior Vice President, Head of Research &

Development, BTG International

* Roger J. Hajjar, MD, Director, Cardiovascular Research Center, Mt.

Sinai School of Medicine, Arthur & Janet C. Ross Professor of Medicine,

Co-founder Celladon Corporation, Co-founder Nanocor Inc.

* Steven J. Heller, Global Marketing Leader, Oncology New Product

Development and Early Commercial Input, Johnson & Johnson Worldwide

Strategic Marketing

* Professor Jutta Heim, PhD, Chief Scientific Officer, Basilea


* Claudia Hirawat, SVP Corporate Development, PTC Therapeutics

* Ginger S. Johnson, PhD, Vice President, Defined Health

* Matthew W. Kalnik, PhD, VP, Business Development & Project Management,

Nabi Biopharmaceuticals

* Jeremy Levin, PhD, Senior Vice President, External Science, Technology

and Licensing, Bristol-Myers Squibb

* Christopher Lipinski, PhD, Scientific Advisor, Melior Discovery

* Joseph S. McCracken, DVM, Vice President, Business & Commercial

Development, Genentech

* David P. Meeker, MD, President, LSD Therapeutics, Genzyme

* Eszter Nagy, MD, PhD, Vice President, Pre-clinical R&D, Intercell

* Steve J. Offord, PhD, Vice President CNS New Products Marketing, Market

Access and Business Development, sanofi-aventis

* Carlos Plata-Salaman, DSc, MD, Head, Global External Research &

Development, Eli Lilly & Co.

* Edward C. Saltzman, President, Defined Health

* Deborah Schrag, MD, Associate Professor of Medicine, Dana-Farber Cancer


* Mark J. Simon, President, Williver Group LLC

* Greg Wiederrecht, PhD, Vice President & Head, External Scientific

Affairs, Merck & Co.

* Daphne Zohar, Founder & Managing Partner, PureTech Ventures

The final agenda, list of speakers and registration information along with content and attendee statistics from prior Therapeutic Insight conferences is available on the conference website,

Shannon Brownlee, Schwartz Senior Fellow at the New America Foundation, will present a keynote address at TI2008 entitled, "Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer." Her book of the same title was named the best economics book of 2007 by the New York Times. Ms. Brownlee's speaking fee will be donated to charity.

The 2+ day conference will include two networking events, with additional opportunities for interaction throughout the event. The conference will begin on Tuesday morning, April 29, with a plenary presentation by Ed Saltzman, President of Defined Health, entitled: "Surviving, Sustaining and Succeeding in the Pursuit of Innovation."

Therapeutic Insight 2008 is presented by Defined Health and Communitech Market Intelligence, with a sponsorship from JNK Securities. To register, or for more information, please visit, or contact Communitech: (914) 245-7764,, or Defined Health: (973) 292-5001,


Ginny E. Llobell

Vice President

Defined Health

973-292-5001 X 235

SOURCE Defined Health
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Sensitivity of brain center for sound space defined
2. Pathway to cell death redefined in landmark study
3. Pathway to cell death redefined in landmark study
4. John Hancock Launches Defined Benefit Program
5. New upper limit defined for normal ALT in adolescent males
6. Shannon Brownlee, Author of Overtreated, to Keynote at Defined Healths 8th Annual Therapeutic Insight Conference
7. Penn study finds pro-death proteins required to regulate healthy immune function
8. UCLA researchers identify markers that may predict diabetes in still-healthy people
9. Air pollution linked to cardiovascular risk indices in healthy young adults
10. More proof needed of safety and quality of electronic personal health records
11. Health care incentive model offers collaborative approach
Post Your Comments:
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: